EUROIMMUN has introduced two ELISAs for the detection of IgM and IgG antibodies against Oropouche virus. Oropouche virus is the causative agent of Oropouche fever, an emerging disease which manifests with dengue-like symptoms such as sudden onset of high fever, myalgia, rash, joint pain and vomiting. The virus circulates in Central and South America and […]
In response to the escalating demand from clinicians and researchers for precise and fast NAD measurement, NADMED has unveiled an innovative technology designed for extracting and measuring all four NADs and two glutathiones. The method is founded on colorimetric quantification, applicable to blood, tissue, or cells.
Tecan is expanding its leading portfolio for specialist applications with the upcoming launch of Resolvex i300 and its antibody purification columns, AffinEx Protein A Capture. The products deliver new levels of efficiency and precision to proteomics workflows, including biomarker discovery, drug development and personalized medicine research.
Beckman Coulter Diagnostics unveiled its new DxC 500 AU Chemistry Analyzer, an automated clinical chemistry analyzer, at Medlab Middle East in Dubai, early February. The DxC 500 AU Chemistry Analyzer is one of several recent Beckman Coulter solutions designed to address the complete needs of healthcare systems that are looking to complement central hub laboratories […]
Proscia, a leading provider of digital and computational pathology solutions, has received US FDA 510(k) clearance for its Concentriq AP-Dx. The digital pathology solution was cleared for the purpose of primary diagnosis and should be used with the Hamamatsu NanoZoomer S360MD Slide scanner in the United States.
Revvity’s software and informatics division, Revvity Signals, has introduced the Signals Clinical solution, a software-as-a-service (SaaS), end-to-end clinical data science platform designed to centralize all clinical trial data, providing fast, actionable insights for quicker clinical decisions and accelerated market delivery of therapeutics.
Azenta has launched their BioArc Ultra (the “Ultra”), a breakthrough, automated solution for high-density, eco-friendly ultracold sample management, designed to provide a new level of performance for large-scale sample management with the potential to forever change the landscape of biorepositories.
Novartis will acquire Calypso Biotech, a developer of Interleukin15 (IL-15) targeted therapies, for US$250 million plus a further $175 million based on the achievement of certain predetermined milestones.
Gilead Sciences will acquire CymaBay Therapeutics for US$4.3 billion. The acquisition will see Gilead add CymaBay’s investigational lead product candidate, seladelpar for the treatment of primary biliary cholangitis (PBC) including pruritus, to their existing liver therapy portfolio.
PrecisionLife, and leading US multi-specialty healthcare center, and Metrodora Institute, are co-investing in a first-of-its-kind partnership to jumpstart the diagnosis and treatment options for a range of complex, chronic diseases including Long COVID, ME/CFS, ALS, Sjögren’s syndrome, and many more. The partners will first develop and validate genotypic diagnostics that provide clinicians with an accurate […]
February | March 2025
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.